Bad blood : (Record no. 35938)
[ view plain ]
| INTERNATIONAL STANDARD BOOK NUMBER | |
|---|---|
| International Standard Book Number | 9781509868087 |
| DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Call number | 338.7681761 CA BA |
| MAIN ENTRY--PERSONAL NAME | |
| Authors | Carreyrou, John |
| TITLE STATEMENT | |
| Title | Bad blood : |
| Subtitle | secrets and lies in a Silicon valley startup / |
| Statement of responsibility, etc | John Carreyrou |
| PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | London : |
| Publisher | Picador, |
| Date | 2019. |
| PHYSICAL DESCRIPTION | |
| Extent | xii, 339 p. ; |
| Size | 20 cm. |
| SUMMARY | |
| Summary | A New York Times Bestseller Longlisted for the Financial Times and McKinsey Business Book of the Year Award 'Chilling ... Reads like a West Coast version of All the President's Men.' New York Times Book Review The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star. The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | Holmes, Elizabeth, 1984- |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | Securities fraud |
| Geographic | United States |
| General | Case studies |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | Fraud |
| Geographic | United States |
| General | Case studies |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | New business enterprises |
| General | Corrupt practices |
| Geographic | United States |
| Form | Case studies |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | Hematologic equipment industry |
| Geographic | United States |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Heading | Fraud |
| Geographic | United States |
| General | Case studies |
| ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | https://uowd.box.com/s/voi1l0hzdxefb6h2nsi3g137q5lpq5h8 |
| Public note | Location Map |
| MAIN ENTRY--PERSONAL NAME | |
| -- | 27877 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 28016 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 28017 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 51337 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 28019 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 27879 |
| SUBJECT ADDED ENTRY--TOPICAL TERM | |
| -- | 51338 |
| Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent location | Current location | Shelving location | Date acquired | Source of acquisition | Full call number | Barcode | Date last seen | Price effective from | Koha item type | Public note |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| University of Wollongong in Dubai | University of Wollongong in Dubai | Main Collection | 2019-05-02 | Virgin Megastore | 338.7681761 CA BA | T0062373 | 2019-05-02 | 2019-05-02 | REGULAR | May 2019 |